Abbvie

This study compares an experimental drug called ABBV-706 against standard chemotherapy treatments for adults whose small cell lung cancer has returned or stopped responding to prior therapy. About 531 participants will be randomly assigned to receive either the new drug or one of…

This study aims to gather real-world information on how well an already-approved Parkinson's disease treatment works and how safe it is for patients in their regular care. About 100 adults with advanced Parkinson's who are newly prescribed this medication by their doctor will be …

This study is testing a new drug called pivekimab sunirine in children and teenagers whose acute myeloid leukemia (AML) has come back or hasn't responded to other treatments. The main goals are to check the drug's safety and see how it moves through the body. About 18 participant…

This study will follow 120 adults in Belgium with advanced Parkinson's disease who are already prescribed a specific medication (Foslevodopa/Foscarbidopa). The goal is to see how well the treatment controls their symptoms in real-life clinic settings, not in a controlled experime…

This study is testing whether adding an experimental drug called telisotuzumab adizutecan to standard chemotherapy works better for people with advanced pancreatic cancer that has spread. About 900 patients worldwide will receive either the new combination or standard treatment a…

This is the first study in people to test a new drug called ABBV-438 for advanced multiple myeloma, a blood cancer that has returned or stopped responding to other treatments. The main goal is to find a safe dose and see how the body processes the drug. About 127 adults worldwide…

This early-stage study aims to understand how two drugs, ABBV-722 and upadacitinib, interact when taken together by healthy adults. It will measure the levels of each drug in the blood and check for side effects. The goal is to gather basic safety data to inform future research, …

This study aims to find out how common a specific protein called folate receptor alpha is in the tumors of people with a certain type of ovarian cancer. Researchers will test about 200 old tissue samples from people whose cancer has returned. The goal is to see if the amount of t…

This early-stage study aims to understand how the drug risankizumab moves through and is processed by the body. It will compare two ways of giving the drug: as an injection under the skin and as an infusion into a vein. The study will enroll 60 healthy volunteers to measure drug …